Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.

Anginex, a designed peptide that inhibits angiogenesis

Open access
Arjan W. Griffioen, Daisy W.J. van der Schaft, Annemarie F. Barendsz-Janson, Andrew COX, Harry A.J. Struijker-Boudier, Harry F P Hillen, Kevin H. Mayo·2001·Biochemical Journal

Abstract

Novel beta-sheet-forming peptide 33-mers, betapep peptides, have been designed by using a combination approach employing basic folding principles and incorporating short sequences from the beta-sheet domains of anti-angiogenic proteins. One of these designed peptides (betapep-25), named anginex, was observed to be potently anti-angiogenic. Anginex specifically inhibits vascular endothelial cell proliferation and induces apoptosis in these cells, as shown by flow-cytometric detection of sub-diploid cells, TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP-nick-end labelling) analysis and cell morphology. Anginex also inhibits endothelial cell adhesion to and migration on different extracellular matrix components. Inhibition of angiogenesis in vitro is demonstrated in the sprout-formation assay and in vivo in the chick embryo chorio-allantoic membrane angiogenesis assay. Comparison of active and inactive betapep sequences allows structure-function relationships to be deduced. Five hydrophobic residues and two lysines appear to be crucial to activity. This is the first report of a designed peptide having a well-defined biological function as a novel cytokine, which may be an effective anti-angiogenic agent for therapeutic use against various pathological disorders, such as neoplasia, rheumatoid arthritis, diabetic retinopathy and restenosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1042/0264-6021:3540233

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 175

Metadata

Authors
Griffioen, A. W., van der Schaft, D. W. J., Barendsz-Janson, A. F., Andrew, C. O. X., Struijker-Boudier, H. A. J., Hillen, H. F. P., & Mayo, K. H.
Venue
Biochemical Journal
Publisher
Portland Press
Published
2001-02-22
Volume
354
Issue
2
Pages
233-233
ISSN
0264-6021 (ISSN-L)
OpenAlex
W2134377171
Cited by
175
References
4
FWCI
2.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anginex, a designed peptide that inhibits angiogenesis. https://app.cochat.ai/papers/10.1042/0264-6021:3540233
The paper
Griffioen, A. W., van der Schaft, D. W. J., Barendsz-Janson, A. F., Andrew, C. O. X., Struijker-Boudier, H. A. J., Hillen, H. F. P., & Mayo, K. H. (2001). Anginex, a designed peptide that inhibits angiogenesis. Biochemical Journal. https://doi.org/10.1042/0264-6021%3A3540233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.